Le Lézard
Classified in: Science and technology, Business
Subjects: EARNINGS, Sales, Conference Call, Webcast, Advisory

NICE Provides Dial-in Details for its First Quarter 2024 Results Teleconference


NICE (Nasdaq: NICE) will announce its first quarter 2024 results on Thursday, May 16, 2024, before the opening of the NASDAQ Stock Exchange.
Later that day, management will host a conference call to discuss the results.

8:30 AM - Eastern
1:30 PM - UK
3:30 PM - Israel

To participate, please call one of the dial-in numbers approximately 15 minutes before the start time:

US: +1-877-407-4018 (toll free) or +1-201-689-8471
Israel: +1-809-406-247 (toll free)
UK: +0-800-756-3429 (toll free)

When prompted please give your name and company.
If you need assistance during the conference, press * then 0 on your telephone and a conference coordinator will be happy to assist you.

The call will be webcast live on the Company's website at https://www.nice.com/company/investors/upcoming-event.

Kind Regards,
NICE Investor Relations

About NICE

NICE (Nasdaq: NICE) is the world's leading provider of both cloud and on-premises enterprise software solutions that empower organizations to make smarter decisions based on advanced analytics of structured and unstructured data. NICE helps organizations of all sizes deliver better customer service, ensure compliance, combat fraud and safeguard citizens. Over 25,000 organizations in more than 150 countries, including over 85 of the Fortune 100 companies, are using NICE solutions. www.nice.com.

Trademark Note: NICE and the NICE logo are trademarks or registered trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICE's marks, please see: www.nice.com/nice-trademarks.


These press releases may also interest you

at 03:40
HTA Group, Ltd (the "Offeror"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces the launch of its offer to purchase for cash any and all of the 7.000% Senior...

at 03:20
In a grand ceremony held on Wednesday in the Russian Embassy in Beijing, two sculptures portraying the renowned Russian novelist Maxim Gorky (1868-1936) and his Chinese counterpart Lu Xun (1881-1936), who was the most influential representative of...

at 03:15
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 03:00
KnowBe4, the provider of the world's largest security awareness training and simulated phishing platform, today released its report on cyber threats faced by the financial sector in the UK. The report examines the escalating rise of cyberattacks on...

at 02:46
OKX, a leading Web3 technology company, has issued updates for May 20, 2024. OKX DEX Incorporates ChangeNOW's Cross-Chain Bridges:...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....



News published on and distributed by: